These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9352354)

  • 1. Polymorphism at beta 85 and not beta 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism.
    Wu S; Gorski J
    Int Immunol; 1997 Oct; 9(10):1495-502. PubMed ID: 9352354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1.
    Natarajan SK; Stern LJ; Sadegh-Nasseri S
    J Immunol; 1999 Mar; 162(6):3463-70. PubMed ID: 10092802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
    Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
    Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of localized HLA class II beta chain polymorphism on binding of antigenic peptide and stimulation of T cells.
    Newton-Nash DK; Eckels DD
    Hum Immunol; 1992 Mar; 33(3):213-23. PubMed ID: 1618659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
    Kropshofer H; Bohlinger I; Max H; Kalbacher H
    Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1.
    Zavala-Ruiz Z; Sundberg EJ; Stone JD; DeOliveira DB; Chan IC; Svendsen J; Mariuzza RA; Stern LJ
    J Biol Chem; 2003 Nov; 278(45):44904-12. PubMed ID: 12952957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
    Schulze MS; Anders AK; Sethi DK; Call MJ
    PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
    Murthy VL; Stern LJ
    Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
    Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
    Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC-peptide conformation and T cell recognition.
    Tate KM; Lee C; Edelman S; Carswell-Crumpton C; Liblau R; Jones PP
    Int Immunol; 1995 May; 7(5):747-61. PubMed ID: 7547702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
    Stratikos E; Mosyak L; Zaller DM; Wiley DC
    J Exp Med; 2002 Jul; 196(2):173-83. PubMed ID: 12119342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.
    Burster T; Macmillan H; Hou T; Schilling J; Truong P; Boehm BO; Zou F; Lau K; Strohman M; Schaffert S; Busch R; Mellins ED
    Immunology; 2010 Jul; 130(3):436-46. PubMed ID: 20331476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
    Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
    Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
    Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
    J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex.
    Wang XX; Li Y; Yin Y; Mo M; Wang Q; Gao W; Wang L; Mariuzza RA
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15960-5. PubMed ID: 21900604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif.
    Kropshofer H; Max H; Müller CA; Hesse F; Stevanovic S; Jung G; Kalbacher H
    J Exp Med; 1992 Jun; 175(6):1799-803. PubMed ID: 1375272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.